PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers

NCT02359344 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Trigeminal Neuralgia

Interventions

DRUG: CNV1014802
DRUG: Placebo

Sponsor

Biogen